Literature DB >> 7273480

Complement-inhibiting and anti-inflammatory properties of chlorazole fast pink 2BL.

N S Doherty.   

Abstract

Chlorazole fast pink 2BL inhibited the classical complement pathway in rat serum both in vivo and in vitro. The in vitro potency of chlorazole fast pink against the alternative pathway could not be assessed accurately but it was clearly less than that against the classical pathway. The compound appears to bind strongly to albumin with a resulting decrease in potency in undiluted as compared to diluted serum. Anti-inflammatory activity was observed in models of inflammation known to be highly complement-dependent (direct passive Arthus, zymosan oedema) but not in models in which complement is not involved (dextran oedema) or plays a minor role (carrageenan oedema).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7273480      PMCID: PMC1537288     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  The quantitation of alternative pathway complement function by timed lysis assay.

Authors:  B M Jones
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

2.  THE INTERACTION BETWEEN CARRAGEENAN AND THE FIRST COMPONENT OF COMPLEMENT.

Authors:  T BORSOS; H J RAPP; C CRISLER
Journal:  J Immunol       Date:  1965-05       Impact factor: 5.422

3.  5-Hydroxytryptamine and the anaphylactoid reaction in the rat.

Authors:  J R PARRATT; G B WEST
Journal:  J Physiol       Date:  1957-11-14       Impact factor: 5.182

4.  The action of mucin in promoting infections: the anticomplementary effect of mucin extracts and certain other substances.

Authors:  H P LAMBERT; J RICHLEY
Journal:  Br J Exp Pathol       Date:  1952-08

5.  A capillary diffusion method for determining hemolytic complement activity in undiluted serum .

Authors:  J A Brockman; N Bauman
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

6.  Disodium cromoglycate and the dextran response in rats.

Authors:  T H Hanahoe; A Holliman; D Gordan; W Wieczorek
Journal:  J Pharm Pharmacol       Date:  1972-08       Impact factor: 3.765

7.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

8.  Anti-inflammatory properties of sulfated polysaccharides and activation of the plasma kinin-forming systems.

Authors:  K Saeki
Journal:  Arch Int Pharmacodyn Ther       Date:  1972-01

9.  Complement in acute inflammation.

Authors:  D A Willoughby; E Coote; J L Turk
Journal:  J Pathol       Date:  1969-02       Impact factor: 7.996

10.  Synthetic modulators of the complement system. 1. Synthesis and biological activity of 5,5',5''-[1,3,6-naphthalenetriyltris(sulfonylimino)]-tris[1,3-benzenedisulfonic acid] hexasodium salt.

Authors:  R B Conrow; N Bauman; J A Brockman; S Bernstein
Journal:  J Med Chem       Date:  1980-03       Impact factor: 7.446

View more
  1 in total

1.  Small-molecule costimulatory blockade: organic dye inhibitors of the CD40-CD154 interaction.

Authors:  Emilio Margolles-Clark; Oliver Umland; Norma S Kenyon; Camillo Ricordi; Peter Buchwald
Journal:  J Mol Med (Berl)       Date:  2009-08-26       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.